Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients

To define the correlation between BCR promoter DNA methylation and response to imatinib in chronic myeloid leukemia (CML), we investigated BCR promoter DNA methylation in three groups of subjects. The first group included chronic phase patients enrolled in an imatinib dose escalation trial. In the t...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: KOH, YOUNGIL, KIM, DAE-YOUNG, PARK, SUNG-HYO, BYUN, HYANG-MIN, KIM, INHO, YOON, SUNG-SOO, KIM, BYOUNG KOOK, PARK, EUNKYUNG, YANG, ALLEN S., PARK, SEONYANG
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2011
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3412470/
https://ncbi.nlm.nih.gov/pubmed/22870150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2010.208
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi